Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Neurol Neurosurg Psychiatry ; 81(10): 1167-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20660916

ABSTRACT

BACKGROUND: Voltage-gated potassium channel antibody-positive limbic encephalitis (VGKC+LE) frequently improves with immunotherapy, although the optimum regimen is unknown. The effectiveness of a combination immunomodulatory regimen was tested in consecutive VGKC+LE patients. METHODS: This was an open-label prospective study of nine VGKC+LE patients. All patients had plasma exchange (50 ml/kg), intravenous immunoglobulin (2 g/kg) and intravenous methylprednisolone (1 g×3), followed by maintenance oral prednisolone (1 mg/kg/day). Mycophenolate (2 g/day) was used in the first three patients. Assessments included serial clinical, cognitive, brain MRI and VGKC antibody testing. RESULTS: Within 1 week, seizures and hyponatraemia remitted in all affected patients. Cognitive function improved in all patients within 3 months. MRI appearances improved substantially within 9 months, with remission of inflammation in the majority of patients. All achieved immunological remission with normal VGKC antibody titres within 1-4 months. Major adverse events of therapy included one septicaemia and one thrombosis on plasma exchange and one death from sepsis after incidental bowel surgery. One patient remains in remission after 40 months of follow up, 26 months after being off all treatment. CONCLUSIONS: Our immunotherapy regimen was effective for the treatment of the clinical, cognitive and immunological features of VGKC+LE. Radiological improvement was seen in the majority. Pending randomised controlled trials, this regimen is proposed for the treatment of VGKC+LE.


Subject(s)
Cognition Disorders/drug therapy , Immunoglobulins/administration & dosage , Limbic Encephalitis/drug therapy , Methylprednisolone/administration & dosage , Mycophenolic Acid/analogs & derivatives , Potassium Channels, Voltage-Gated/immunology , Prednisolone/therapeutic use , Aged , Anti-Inflammatory Agents/administration & dosage , Cognition Disorders/complications , Drug Therapy, Combination , Female , Humans , Immunologic Factors/administration & dosage , Immunosuppressive Agents/therapeutic use , Limbic Encephalitis/complications , Limbic Encephalitis/immunology , Magnetic Resonance Imaging , Male , Middle Aged , Mycophenolic Acid/therapeutic use , Serotyping
2.
Aliment Pharmacol Ther ; 22(10): 917-25, 2005 Nov 15.
Article in English | MEDLINE | ID: mdl-16268965

ABSTRACT

Acute colonic pseudo-obstruction is the clinical syndrome of acute large bowel dilatation without mechanical obstruction that is an important cause of morbidity and mortality. Acute colonic pseudo-obstruction occurs in hospitalized or institutionalized patients with serious underlying medical and surgical conditions. The pathogenesis of acute colonic pseudo-obstruction is not completely understood but likely results from an imbalance in the autonomic regulation of colonic motor function. Metabolic or pharmacological factors, as well as spinal or retroperitoneal trauma, may alter the autonomic regulation of colonic function, leading to excessive parasympathetic suppression or sympathetic stimulation. This imbalance results in colonic atony and dilatation. Early recognition and appropriate management are critical to minimizing morbidity and mortality. The mortality rate is estimated at 40% when ischaemia or perforation occurs. The best-studied treatment of acute colonic pseudo-obstruction is intravenous neostigmine, which leads to prompt colon decompression in the majority of patients after a single infusion. In patients failing or having contraindications to neostigmine, colonoscopic decompression is the active intervention of choice. Surgery is reserved for those with peritonitis or perforation.


Subject(s)
Colonic Pseudo-Obstruction/therapy , Neostigmine/therapeutic use , Parasympathomimetics/therapeutic use , Acute Disease , Colonic Pseudo-Obstruction/diagnostic imaging , Humans , Patient Care Management , Radiography
4.
Am J Gastroenterol ; 96(2): 385-93, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11232680

ABSTRACT

OBJECTIVE: Severe GI bleeding after hematopoietic cell transplantation is commonly due to lesions that are unusual in nontransplant patients. The frequency of GI bleeding appears to have decreased over the last decade, but the reasons have not been readily apparent. We sought to determine the incidence of severe bleeding during two time periods, to describe the causes and outcomes of bleeding, and to analyze the reasons behind an apparent decline in severe bleeding over the decade covered. METHODS: During 1986-1987 and 1996-1997, we followed all patients with and without severe bleeding at our institution, a marrow transplant center. RESULTS: Over this decade, the incidence of severe bleeding declined from 50/467 (10.7%) to 15/635 (2.4%) (p < 0.0001). Overall mortality from intestinal bleeding declined from 3.6% to 0.9% (p = 0.002), but mortality in those with bleeding remained high (34% vs 40%). The onset (day 42 vs 47) and platelet counts (35,994 vs 37,600/microl) were similar, but the sites and causes of bleeding were different. During 1986-1987, 27/50 patients bled from multiple GI sites, viral and fungal ulcers, or graft-versus-host disease (GVHD). Over the decade, bleeding from GVHD had decreased 80% (p < 0.0001), and bleeding from viral (p < 0.0001) and fungal (p = 0.023) ulcers almost disappeared. CONCLUSIONS: The incidence of severe GI bleeding has declined significantly over the last decade because of prevention of viral and fungal infections and severe acute GVHD. However, severe bleeding after transplant remains a highly morbid event, particularly among patients with GVHD.


Subject(s)
Gastrointestinal Hemorrhage/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Adult , Blood Transfusion , Cohort Studies , Female , Follow-Up Studies , Gastrointestinal Hemorrhage/epidemiology , Gastrointestinal Hemorrhage/therapy , Graft vs Host Disease/prevention & control , Humans , Incidence , Male , Opportunistic Infections/prevention & control , Prospective Studies , Risk Factors
5.
Am J Surg Pathol ; 24(7): 1004-8, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10895823

ABSTRACT

BACKGROUND: Acute graft-versus-host disease (GVHD) of the liver is a frequent complication of allogeneic hematopoietic cell transplantation. This report describes hepatic GVHD following autologous transplantation. METHODS: We reviewed 116 consecutive autologous transplant recipients. A diagnosis of GVHD was based on histology (segmental to subtotal destruction of bile ductal epithelial cells with apoptosis and lymphocytic infiltrates), clinical criteria (elevated serum alkaline phosphatase), a response to immunosuppressive therapy, and finding no other cause for cholestatic liver disease. RESULTS: Two patients developed cholestatic liver disease (alkaline phosphatase levels over five times the normal upper limit) and had liver biopsies showing apoptotic and dysmorphic ductular epithelial cells typical of GVHD. Three additional patients developed cholestasis and intestinal symptoms but had gastric biopsies only, showing apoptotic crypt epithelial cells and crypt cell drop-out typical of GVHD. CONCLUSION: Two recipients of autologous hematopoietic cells developed histologic abnormalities of small bile ducts and cholestatic liver disease resembling GVHD of the liver after allogeneic transplant. The mechanisms of bile duct damage in this setting may involve immune dysregulation related to reconstitution of immunity with peripheral blood stem cells.


Subject(s)
Apoptosis , Bile Ducts, Intrahepatic/pathology , Cholestasis/pathology , Graft vs Host Disease/pathology , Hematopoietic Stem Cell Transplantation/adverse effects , Acute Disease , Alkaline Phosphatase/blood , Cholestasis/drug therapy , Cholestasis/etiology , Epithelial Cells/pathology , Female , Graft vs Host Disease/drug therapy , Graft vs Host Disease/etiology , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Prednisone/therapeutic use
6.
N Engl J Med ; 341(3): 137-41, 1999 Jul 15.
Article in English | MEDLINE | ID: mdl-10403850

ABSTRACT

BACKGROUND: Acute colonic pseudo-obstruction -- that is, massive dilation of the colon without mechanical obstruction -- may develop after surgery or severe illness. Although it may resolve with conservative therapy, colonoscopic decompression is sometimes needed to prevent ischemia and perforation of the bowel. Uncontrolled studies have suggested that neostigmine, may be an effective treatment. METHODS: We studied 21 patients with acute colonic pseudo-obstruction. All had abdominal distention and radiographic evidence of colonic dilation, with a cecal diameter of at least 10 cm, and had had no response to at least 24 hours of conservative treatment. We randomly assigned 11 to receive 2.0 mg of neostigmine intravenously and 10 to receive intravenous saline. A physician who was unaware of the patients' treatment assignments recorded clinical response (defined as prompt evacuation of flatus or stool and a reduction in abdominal distention), abdominal circumference, and measurements of the colon on radiographs. Patients who had no response to the initial injection were eligible to receive open-label neostigmine three hours later. RESULTS: Ten of the 11 patients who received neostigmine had prompt colonic decompression, as compared with none of the 10 patients who received placebo (P<0.001). The median time to response was 4 minutes (range, 3 to 30). Seven patients in the placebo group and the one patient in the neostigmine group without an initial response received open-label neostigmine; all had colonic decompression. Two patients who had an initial response to neostigmine required colonoscopic decompression for recurrence of colonic distention; one eventually underwent subtotal colectomy. Side effects of neostigmine included abdominal pain, excess salivation, and vomiting. Symptomatic bradycardia developed in two patients and was treated with atropine. CONCLUSIONS: In patients with acute colonic pseudo-obstruction who have not had a response to conservative therapy, treatment with neostigmine rapidly decompresses the colon.


Subject(s)
Cholinesterase Inhibitors/therapeutic use , Colonic Pseudo-Obstruction/drug therapy , Neostigmine/therapeutic use , Abdominal Pain/chemically induced , Acute Disease , Adult , Aged , Aged, 80 and over , Cholinesterase Inhibitors/adverse effects , Double-Blind Method , Female , Humans , Male , Middle Aged , Neostigmine/adverse effects , Recurrence
7.
Res Dev Disabil ; 19(2): 99-122, 1998.
Article in English | MEDLINE | ID: mdl-9547523

ABSTRACT

The rates and durations of stereotypic behaviors in four adolescents with severe mental retardation were measured during two daily vocational training sessions and during contiguous periods of leisure in their special education classrooms. Vocational training was conducted in two different tasks, alternating across days. The task requirements for each participant were matched to each participant's learning and performance characteristics. The participants were exposed to a fixed ratio schedule of tokens exchangeable for food items on one task and to a variable interval schedule for the same consequences on the second task. The schedules were chosen as an initial test of a matching-law based prediction by Myerson and Hale (1984): Variable interval reinforcement for adaptive behavior will produce less allocation of responding to maladaptive behavior than will a ratio-based intervention. When work performances stabilized, the schedules of token delivery were reversed across the tasks and performances again stabilized. Results are reported for periods when work performances met stability criteria. Stereotypy occurred more during leisure than during vocational training under either schedule. The major differences in stereotypy between leisure and vocational training were differences in episode length rather than rate of onset. Onset of stereotypy in vocational training, however, occurred at higher rates under the interval schedule than under the ratio schedule in both tasks. The results are discussed in terms of Myerson and Hale's prediction and implications for further research and application.


Subject(s)
Behavior Therapy/methods , Intellectual Disability/rehabilitation , Reinforcement Schedule , Stereotyped Behavior , Vocational Education , Adolescent , Child , Education of Intellectually Disabled , Female , Humans , Intellectual Disability/psychology , Leisure Activities , Male , Token Economy
8.
Res Dev Disabil ; 14(1): 1-18, 1993.
Article in English | MEDLINE | ID: mdl-8469795

ABSTRACT

A technology incorporating bar code symbols and hand-held optical scanners was evaluated for its utility for routine data collection in a special education classroom. A different bar code symbol was created for each Individualized Educational Plan objective, each type of response occurrence, and each student in the first author's classroom. These symbols were organized by activity and printed as data sheets. The teacher and paraprofessionals scanned relevant codes with scanners when the students emitted targeted behaviors. The codes, dates, and approximate times of the scans were retained in the scanner's electronic memory until they could be transferred by communication software to a computer file. The data from the computer file were organized weekly into a printed report of student performance using a program written with commercially available database software. Advantages, disadvantages, and costs of using the system are discussed.


Subject(s)
Data Collection/instrumentation , Disabled Persons/education , Education, Special , Electronic Data Processing , Microcomputers , Child , Computer Graphics , Computer Systems , Documentation/methods , Humans , Software
9.
Am J Gastroenterol ; 84(2): 192-4, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2563628

ABSTRACT

A patient with an ileocolectomy and proximal ileostomy for Crohn's disease had severe diarrhea and steatorrhea. An oral electrolyte solution containing glucose polymer was shown to improve water and electrolyte absorption. Ileal contents were abnormally acidic. Therapy with an H2-receptor blocker raised ileal pH, improved the efficiency of fat absorption, and promoted a gain in body weight.


Subject(s)
Crohn Disease/surgery , Fluid Therapy , Histamine H2 Antagonists/therapeutic use , Ileostomy/adverse effects , Malabsorption Syndromes/therapy , Thiazoles/therapeutic use , Adult , Carbohydrates/administration & dosage , Combined Modality Therapy , Famotidine , Humans , Malabsorption Syndromes/etiology , Male , Polymers/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...